专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2011008001A3 ANTIHYPERTENSIVE COMPOSITION CONTAINING A GINSENOSIDE-ENRICHED FRACTION 审中-公开
标题翻译：含人参皂苷丰富组分的抗高血压组合物
公开(公告)号：WO2011008001A3
公开(公告)日：2011-05-19
申请号：PCT/KR2010004536
申请日：2010-07-13
申请人： CJ CHEILJEDANG CORP , KIM HYE-JIN , KIM SE-GON , LEE JIN-HEE , PARK SEOK-JUN , KIM YEONG-EUN , KWON ORAN
发明人： KIM HYE-JIN , KIM SE-GON , LEE JIN-HEE , PARK SEOK-JUN , KIM YEONG-EUN , KWON ORAN
IPC分类号： A61K31/704 , A23L1/30 , A61K9/14 , A61P9/12
CPC分类号： A61K9/0095 , A23L33/105 , A23V2002/00 , A61K31/704 , A61K36/258 , A23V2250/21 , A23V2200/326
摘要： The present invention relates to an antihypertensive composition containing a fraction enriched with ginsenosides of ginseng. The composition according to the present invention increases the production of nitric oxide through the activation of nitric oxide synthase, and thus exhibits superior antihypertensive effects through the vasodilatory activity. Consequently, the composition of the present invention can be used as a composition for preparing functional health foods for preventing and treating hypertension and various cardiovascular diseases caused by complications of hypertension.
摘要翻译：本发明涉及含有富含人参皂苷的部分的抗高血压组合物。根据本发明的组合物通过激活一氧化氮合酶增加一氧化氮的产生，因此通过血管舒张活性表现出优异的抗高血压作用。因此，本发明的组合物可以用作制备用于预防和治疗由高血压并发症引起的高血压和各种心血管疾病的功能性保健食品的组合物。

2. 发明申请

WO2006057505A1 NOVEL COMPOUNDS AS AGONIST FOR PPARγ AND PPARα, METHOD FOR PREPARATION OF THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME 审中-公开
标题翻译：新的化合物作为PPAR的助剂？和PPARα，其制备方法和含有其的药物组合物
公开(公告)号：WO2006057505A1
公开(公告)日：2006-06-01
申请号：PCT/KR2005/003943
申请日：2005-11-22
申请人： LG Life Sciences, Ltd. , KIM, Geun Tae , KOH, Jong Sung , HAN, Hee Oon , KIM, Seung Hae , KIM, Kyoung-Hee , CHUNG, Hee-Kyung , HONG, Sung Woon , LEE, Chang-Seok , KOO, Ki Dong , YIM, Hyeon Joo , HUR, Gwong-Cheung , KIM, Hye Jin , PARK, Ok Ku , LEE, Hyun Mi , WOO, Sung Ho
发明人： KIM, Geun Tae , KOH, Jong Sung , HAN, Hee Oon , KIM, Seung Hae , KIM, Kyoung-Hee , CHUNG, Hee-Kyung , HONG, Sung Woon , LEE, Chang-Seok , KOO, Ki Dong , YIM, Hyeon Joo , HUR, Gwong-Cheung , KIM, Hye Jin , PARK, Ok Ku , LEE, Hyun Mi , WOO, Sung Ho
IPC分类号： C07C251/34
CPC分类号： C07C309/66 , C07D263/32 , C07D265/22 , C07D271/06 , C07D277/24
摘要： The present invention relates to novel compounds accelerating the activity of Peroxisome proliferator-activated receptor gamma (PPARγ) and alpha (PPARα), processes of preparing the same, and pharmaceutical compositions containing the same as an active agent.
摘要翻译：本发明涉及促进过氧化物酶体增殖物激活受体γ（PPARγ）和α（PPARα）的活性的新化合物，其制备方法以及含有它们作为活性剂的药物组合物。

3. 发明申请

WO2013009072A2 BPM-BASED PORT COMMUNITY SYSTEM 审中-公开
标题翻译：基于BPM的港口社区系统
公开(公告)号：WO2013009072A2
公开(公告)日：2013-01-17
申请号：PCT/KR2012005462
申请日：2012-07-10
申请人： TOTAL SOFT BANK LTD , BAE HYE RIM , PARK JAE HUN , LEE HOON , LEE CHAE MIN , SEO CHANG SEOK , LEE SEUNG IL , KIM HYE JIN
发明人： BAE HYE RIM , PARK JAE HUN , LEE HOON , LEE CHAE MIN , SEO CHANG SEOK , LEE SEUNG IL , KIM HYE JIN
IPC分类号： G06Q10/08 , G06Q10/10
CPC分类号： G06Q10/06
摘要： The present invention relates to a port community system which can integrate and operate a plurality of discrete systems associated with ports. The port community system according to the present invention comprises: an external independent module including one or more of a vessel customs system (VCS), a marine service system (MSS), a cargo information management system (CMS) and a free trade zone system (Fzone), which are re-engineered so as to integrate different work processes of each port; an interface module which extracts said one or more systems from the external dependent module by means of a web server; a driving module which drives the system extracted by the interface module by means of a business process management (BPM) process engine, and executes a work process of the extracted system; a design module which enables a re-design and modification of the work process of the extracted system by means of a BPM process designer; a database module which stores various port data from the external independent module and from the driving module; and a control module which controls each of said modules. Thus, a single integrated system which can control and carry out various duties associated with ports is provided.
摘要翻译：本发明涉及能够集成和操作与端口相关联的多个离散系统的端口社区系统。根据本发明的港口社区系统包括：外部独立模块，其包括船舶海关系统（VCS），海运服务系统（MSS），货物信息管理系统（CMS）和自由贸易区系统中的一个或多个（Fzone），重新设计，以便整合每个港口的不同工作流程; 接口模块，其通过web服务器从外部依赖模块中提取所述一个或多个系统; 驱动模块，其通过业务过程管理（BPM）处理引擎驱动由接口模块提取的系统，并执行所提取的系统的工作过程; 一种设计模块，其能够通过BPM过程设计者重新设计和修改所提取的系统的工作过程; 数据库模块，其存储来自外部独立模块和来自驱动模块的各种端口数据; 以及控制模块，其控制每个所述模块。因此，提供了可以控制和执行与端口相关联的各种职责的单个集成系统。

4. 发明申请

WO2012081842A3 ADHESIVE COMPOSITION FOR SEMICONDUCTORS, ADHESIVE FILM USING SAME, AND USES THEREOF 审中-公开
标题翻译：半导体用粘合剂组合物，使用该粘合剂膜的粘合剂组合物及其用途
公开(公告)号：WO2012081842A3
公开(公告)日：2012-09-07
申请号：PCT/KR2011008775
申请日：2011-11-16
申请人： CHEIL IND INC , PYUN AH RAM , UH DONG SEON , SONG KI TAE , KIM IN HWAN , KIM HYE JIN
发明人： PYUN AH RAM , UH DONG SEON , SONG KI TAE , KIM IN HWAN , KIM HYE JIN
IPC分类号： C09J133/04 , C09J11/06 , C09J163/00 , H01L21/58
CPC分类号： H01L24/29 , C08L63/00 , C09J133/066 , C09J133/18 , H01L24/13 , H01L24/16 , H01L24/32 , H01L24/81 , H01L24/83 , H01L24/92 , H01L25/0657 , H01L25/50 , H01L2224/13111 , H01L2224/13147 , H01L2224/16146 , H01L2224/29101 , H01L2224/2919 , H01L2224/2929 , H01L2224/293 , H01L2224/29386 , H01L2224/32145 , H01L2224/73104 , H01L2224/81011 , H01L2224/81191 , H01L2224/81193 , H01L2224/81203 , H01L2224/81447 , H01L2224/8181 , H01L2224/81815 , H01L2224/83191 , H01L2224/83203 , H01L2224/8385 , H01L2224/9211 , H01L2225/06513 , H01L2225/06541 , H01L2924/01005 , H01L2924/01006 , H01L2924/01012 , H01L2924/0102 , H01L2924/01029 , H01L2924/01033 , H01L2924/01047 , H01L2924/01079 , H01L2924/01327 , H01L2924/014 , H01L2924/0665 , H01L2924/00014 , H01L2224/81 , H01L2224/83 , H01L2924/00
摘要： According to the present invention, the adhesive composition for semiconductors is characterized by comprising an acryl polymer resin, an epoxy resin, and an imidazole compound having a melting point of about 200°C or higher. The present invention relates to a highly fluid adhesive composition for semiconductors, to an adhesive film using the adhesive composition, and to a semiconductor package using same, wherein the adhesive composition for semiconductors ensures electrical connection reliability between bump chips, serves as an adhesive layer between the bump chips to enable fluxing to remove the oxide film of the solder and the Cu bumps, and ensures sufficient contact between the bumps and the solder during chip bonding by thermocompression.
摘要翻译：根据本发明，用于半导体的粘合剂组合物的特征在于包含丙烯酰基聚合物树脂，环氧树脂和熔点为约200℃或更高的咪唑化合物。本发明涉及用于半导体的高流动性粘合剂组合物，涉及使用该粘合剂组合物的粘合剂膜和使用该粘合剂组合物的半导体封装件，其中半导体用粘合剂组合物确保凸块之间的电连接可靠性，该凸块芯片能够通过助焊剂去除焊料和Cu凸块的氧化膜，并且通过热压缩在芯片结合期间确保凸块和焊料之间的充分接触。

5. 发明申请

WO2010110622A9 NOVEL CRYSTAL FORMS OF ADEFOVIR DIPIVOXIL AND PROCESSES FOR PREPARING THE SAME 审中-公开
标题翻译： ADEFOVIR双组分的新型晶体形式及其制备方法
公开(公告)号：WO2010110622A9
公开(公告)日：2011-02-03
申请号：PCT/KR2010001867
申请日：2010-03-26
申请人： DAE WOONG PHARMA , DAEWOONG BIO INC , CHOI SOO JIN , LEE BYUNG GOO , OH SEONG SOO , KIM YONG TAE , KIM KWANG JOO , KIM HYE JIN
发明人： CHOI SOO JIN , LEE BYUNG GOO , OH SEONG SOO , KIM YONG TAE , KIM KWANG JOO , KIM HYE JIN
IPC分类号： C07D473/34 , C07F9/28
CPC分类号： C07D473/34 , C07F9/65616
摘要： The present invention relates to novel Forms A, B, C, D, E, F and G of crystalline 9-[2-[phosphonomethoxy]ethyl]adenine bis-pivaloyloxymethyl ester, i.e., adefovir dipivoxil, and processes for preparing them. According to the present invention, said novel crystal forms having a high purity can be obtained by a simple method and in a high yield.
摘要翻译：本发明涉及结晶9- [2- [膦酰甲氧基]乙基]腺嘌呤双新戊酰氧基甲基酯即阿德福韦酯的新形式A，B，C，D，E，F和G及其制备方法。根据本发明，可以通过简单的方法和高产率获得具有高纯度的所述新型晶体形式。

6. 发明申请

WO2007114550A1 A NOVEL MONOCLONAL ANTIBODY SPECIFIC TO THE L1CAM, A HYBRIDOMA PRODUCING THE SAME AND A METHOD PRODUCING THE SAME 审中-公开
标题翻译：特异于L1CAM的新型单克隆抗体，其生产方法的混合物及其生产方法
公开(公告)号：WO2007114550A1
公开(公告)日：2007-10-11
申请号：PCT/KR2006/004699
申请日：2006-11-10
申请人： KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY , HONG, Hyo Jeong , RYU, Chun Jeih , LEE, Jung Whoi , LEE, Young Kwan , YOUN, Hee Kwan , LEE, Eung Suck , CHOI, Hong Seo , SON, Yeon Sung , KIM, Hye Jin , KIM, Bong Hui , KIM, Jin Man , KIM, Dae Ghon
发明人： HONG, Hyo Jeong , RYU, Chun Jeih , LEE, Jung Whoi , LEE, Young Kwan , YOUN, Hee Kwan , LEE, Eung Suck , CHOI, Hong Seo , SON, Yeon Sung , KIM, Hye Jin , KIM, Bong Hui , KIM, Jin Man , KIM, Dae Ghon
IPC分类号： C07K16/30
CPC分类号： C07K16/2803 , A61K2039/505 , C07K16/30 , C07K2317/73 , C07K2317/76
摘要： The present invention relates to a monoclonal antibody that specifically binds to LlCAM protein. The novel antibody A10-A3 according to the present invention can specifically bind to the LlCAM protein, which is expressed in various cancers including cholangiocarcinoma and lung cancer, so as to suppress the growth, invasion, and migration of the cancer cells.
摘要翻译：本发明涉及特异性结合L1CAM蛋白的单克隆抗体。根据本发明的新型抗体A10-A3可以特异性结合L1CAM蛋白，其在包括胆管癌和肺癌的各种癌症中表达，以抑制癌细胞的生长，侵袭和迁移。

7. 发明申请

WO2005120566A1 DENDRITE CELLS TRANSDUCED WITH RECOMBINANT ADENOVIRUS ADVCEA WHICH GENERATE CEA-SPECIFIC CYTOTOXIC T LYMPHOCYTES, VACCINE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME 审中-公开
标题翻译：用重组腺病毒转运的细胞细胞，其产生特异性细胞毒素T淋巴细胞，包含其的疫苗和药物组合物
公开(公告)号：WO2005120566A1
公开(公告)日：2005-12-22
申请号：PCT/KR2004/001400
申请日：2004-06-11
申请人： KIM, Tai-gyu , CHO, Hyun-il , KIM, Hye-jin , OH, Seoug-taek
发明人： KIM, Tai-gyu , CHO, Hyun-il , KIM, Hye-jin , OH, Seoug-taek
IPC分类号： A61K39/235
CPC分类号： C07K14/70503 , A61K48/00 , A61K2039/5158 , A61K2039/53 , C12N2710/10043
摘要： The present invention relates to an antitumor immune response, and in more detail, to a method for inducing cytotoxic T lymphocytes specific to a tumor-associated antigen that acts specifically on tumor cells. Immunotherapy using the present invention may be most effective among immune therapies that use immunity of our body, because in the present invention, CEA-specific cytotoxic T lymphocytes can be induced in vitro by using a dendritic cell transduced with a recombinant adenovirus. Further, immunotherapy using the present invention can function as a powerful tool (10) for tumor prevention or treatment, if being used in combination with antitumor vaccines or other treatments.
摘要翻译：本发明涉及抗肿瘤免疫应答，并且更详细地涉及诱导特异性作用于肿瘤细胞的肿瘤相关抗原特异性的细胞毒性T淋巴细胞的方法。使用本发明的免疫治疗在使用我们身体免疫的免疫疗法中可能是最有效的，因为在本发明中，可以通过使用用重组腺病毒转导的树突状细胞在体外诱导CEA特异性细胞毒性T淋巴细胞。此外，如果与抗肿瘤疫苗或其他治疗组合使用，则使用本发明的免疫治疗可以用作肿瘤预防或治疗的有力工具（10）。

8. 发明申请

WO2006104356A1 DIPEPTIDYL PEPTIDASE-IV INHIBITING COMPOUNDS, METHODS OF PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE AGENT 审中-公开
标题翻译： DIPEPTIDYL PEPTIDASE-IV抑制化合物，其制备方法和含有它们的药物组合物作为活性剂
公开(公告)号：WO2006104356A1
公开(公告)日：2006-10-05
申请号：PCT/KR2006/001169
申请日：2006-03-30
申请人： LG LIFE SCIENCES, LTD. , LEE, Chang-Seok , KOH, Jong Sung , KOO, Ki Dong , KIM, Geun Tae , KIM, Kyoung-Hee , HONG, Sang Yong , KIM, Sungsub , KIM, Min-Jung , YIM, Hyeon Joo , LIM, Dongchul , KIM, Hye Jin , HAN, Hee Oon , BU, Seong Cheol , KWON, Oh Hwan , KIM, Sung Ho , HUR, Gwong-Cheung , KIM, Ji Young , YEOM, Zi-Ho , YEO, Dong-Jun
发明人： LEE, Chang-Seok , KOH, Jong Sung , KOO, Ki Dong , KIM, Geun Tae , KIM, Kyoung-Hee , HONG, Sang Yong , KIM, Sungsub , KIM, Min-Jung , YIM, Hyeon Joo , LIM, Dongchul , KIM, Hye Jin , HAN, Hee Oon , BU, Seong Cheol , KWON, Oh Hwan , KIM, Sung Ho , HUR, Gwong-Cheung , KIM, Ji Young , YEOM, Zi-Ho , YEO, Dong-Jun
IPC分类号： C07D471/04
CPC分类号： C07D487/04 , C07D401/06 , C07D413/06 , C07D471/04 , C07D498/04 , C07D513/04
摘要： The present invention relates to novel compounds exhibiting good inhibitory activity versus Dipeptidyl Peptidase-IV(DPP-IV), methods of preparing the same and pharmaceutical compositions containing the same as an active agent.
摘要翻译：本发明涉及相对于二肽基肽酶-IV（DPP-IV）显示出良好抑制活性的新化合物，其制备方法和含有该活性剂的药物组合物。

9. 发明申请

WO2010110622A3 NOVEL CRYSTAL FORMS OF ADEFOVIR DIPIVOXIL AND PROCESSES FOR PREPARING THE SAME 审中-公开
标题翻译：新型水杨酸的新型水晶形式及其制备方法
公开(公告)号：WO2010110622A3
公开(公告)日：2011-03-24
申请号：PCT/KR2010001867
申请日：2010-03-26
申请人： DAE WOONG PHARMA , DAEWOONG BIO INC , CHOI SOO JIN , LEE BYUNG GOO , OH SEONG SOO , KIM YONG TAE , KIM KWANG JOO , KIM HYE JIN
发明人： CHOI SOO JIN , LEE BYUNG GOO , OH SEONG SOO , KIM YONG TAE , KIM KWANG JOO , KIM HYE JIN
IPC分类号： C07D473/34 , C07F9/28
CPC分类号： C07D473/34 , C07F9/65616
摘要： The present invention relates to novel Forms A, B, C, D, E, F and G of crystalline 9-[2-[phosphonomethoxy]ethyl]adenine bis-pivaloyloxymethyl ester, i.e., adefovir dipivoxil, and processes for preparing them. According to the present invention, said novel crystal forms having a high purity can be obtained by a simple method and in a high yield.
摘要翻译：本发明涉及结晶9- [2- [膦基甲氧基]乙基]腺嘌呤双新戊酰氧基甲酯（即阿德福韦酯）的新型形式A，B，C，D，E，F和G及其制备方法。根据本发明，可以通过简单的方法和高产率获得具有高纯度的所述新型晶体形式。

10. 发明申请

WO2010110622A2 NOVEL CRYSTAL FORMS OF ADEFOVIR DIPIVOXIL AND PROCESSES FOR PREPARING THE SAME 审中-公开
标题翻译：新型水杨酸的新型水晶形式及其制备方法
公开(公告)号：WO2010110622A2
公开(公告)日：2010-09-30
申请号：PCT/KR2010/001867
申请日：2010-03-26
申请人： DAEWOONG PHARMACEUTICAL CO., LTD. , DAEWOONG BIO INC. , CHOI, Soo Jin , LEE, Byung Goo , OH, Seong Soo , KIM, Yong Tae , KIM, Kwang Joo , KIM, Hye Jin
发明人： CHOI, Soo Jin , LEE, Byung Goo , OH, Seong Soo , KIM, Yong Tae , KIM, Kwang Joo , KIM, Hye Jin
IPC分类号： C07D473/34 , C07F9/28
CPC分类号： C07D473/34 , C07F9/65616
摘要： The present invention relates to novel Forms A, B, C, D, E, F and G of crystalline 9-[2-[phosphonomethoxy]ethyl]adenine bis-pivaloyloxymethyl ester, i.e., adefovir dipivoxil, and processes for preparing them. According to the present invention, said novel crystal forms having a high purity can be obtained by a simple method and in a high yield.
摘要翻译：本发明涉及结晶9- [2- [膦基甲氧基]乙基]腺嘌呤双新戊酰氧基甲酯（即阿德福韦酯）的新型形式A，B，C，D，E，F和G及其制备方法。根据本发明，可以通过简单的方法和高产率获得具有高纯度的所述新型晶体形式。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式